REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q4 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $41,852,901 | -14.2% | 1,845,366 | 0.0% | 0.85% | -24.0% |
Q3 2022 | $48,773,000 | +7.0% | 1,845,366 | 0.0% | 1.12% | -4.6% |
Q2 2022 | $45,581,000 | -25.6% | 1,845,366 | 0.0% | 1.18% | -7.1% |
Q1 2022 | $61,248,000 | +1.5% | 1,845,366 | 0.0% | 1.27% | +43.9% |
Q4 2021 | $60,343,000 | -22.0% | 1,845,366 | 0.0% | 0.88% | -24.5% |
Q3 2021 | $77,358,000 | +13.3% | 1,845,366 | +5.0% | 1.17% | +13.3% |
Q2 2021 | $68,288,000 | +380.6% | 1,757,743 | +321.9% | 1.03% | +364.0% |
Q1 2021 | $14,209,000 | +11.0% | 416,577 | +47.6% | 0.22% | +3.3% |
Q4 2020 | $12,803,000 | +46.1% | 282,260 | -11.4% | 0.22% | +1.9% |
Q3 2020 | $8,763,000 | -24.7% | 318,434 | +0.8% | 0.21% | -35.5% |
Q2 2020 | $11,639,000 | +14.6% | 316,028 | +0.8% | 0.33% | -25.2% |
Q1 2020 | $10,155,000 | -18.9% | 313,606 | +2.6% | 0.44% | -7.4% |
Q4 2019 | $12,521,000 | +20.8% | 305,611 | +5.0% | 0.47% | -23.4% |
Q3 2019 | $10,366,000 | -45.2% | 291,168 | -20.9% | 0.62% | -39.0% |
Q2 2019 | $18,906,000 | -26.9% | 368,040 | -18.4% | 1.01% | -42.8% |
Q1 2019 | $25,857,000 | -41.3% | 451,182 | -57.0% | 1.76% | -57.0% |
Q4 2018 | $44,058,000 | -60.0% | 1,050,245 | -28.0% | 4.10% | -37.8% |
Q3 2018 | $110,164,000 | -26.2% | 1,459,128 | -29.8% | 6.60% | -38.7% |
Q2 2018 | $149,208,000 | +166.2% | 2,079,555 | +10.7% | 10.76% | +101.7% |
Q1 2018 | $56,051,000 | +8.0% | 1,877,767 | +20.3% | 5.33% | -38.4% |
Q4 2017 | $51,910,000 | +2.4% | 1,561,210 | +1.4% | 8.66% | -1.9% |
Q3 2017 | $50,710,000 | +101.7% | 1,539,005 | +20.9% | 8.83% | +66.7% |
Q2 2017 | $25,137,000 | +7.1% | 1,272,770 | +4.6% | 5.30% | -14.3% |
Q1 2017 | $23,479,000 | +427.9% | 1,216,505 | +407.3% | 6.18% | +269.2% |
Q4 2016 | $4,448,000 | +33.0% | 239,789 | +0.4% | 1.67% | +65.6% |
Q3 2016 | $3,345,000 | +72.2% | 238,740 | -1.7% | 1.01% | +52.5% |
Q2 2016 | $1,942,000 | -25.5% | 242,784 | +0.6% | 0.66% | -29.9% |
Q1 2016 | $2,606,000 | -29.1% | 241,323 | +9.0% | 0.95% | -22.1% |
Q4 2015 | $3,674,000 | -18.4% | 221,326 | +8.2% | 1.21% | -13.3% |
Q3 2015 | $4,505,000 | – | 204,494 | – | 1.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |